Private-equity firms have sharply slowed their serial acquisitions of smaller medical businesses, deals that U.S. antitrust regulators say often unfairly reduce competition and harm patients. This year there have been 180 private-equity add-on deals—transactions in which a buyout firm acquires a company to combine with one the firm already owns—in the U.S. healthcare sector through May 28, just 23% of last year’s full-year total, according to data-tracking firm PitchBook Data. While all private-equity activity is down this year, healthcare roll-ups are down more sharply.
Read the full article: Private Equity Puts Brakes on Healthcare Roll-Ups after Government Scrutiny //
Source: https://www.wsj.com/articles/private-equity-puts-brakes-on-healthcare-roll-ups-after-government-scrutiny-6fc64f5a